{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260512566395/en/Alkermes-Announces-Positive-Topline-Results-From-REVITALYZ%E2%84%A0-Phase-3-Study-Evaluating-LUMRYZ%C2%AE-sodium-oxybate-Extended-Release-in-Adults-With-Idiopathic-Hypersomnia", "message": "News view counter 718946 successfully enlarged"}